• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

血清 PCSK9 水平升高与 2 型糖尿病患者的肾功能损害有关。

Increased serum PCSK9 levels are associated with renal function impairment in patients with type 2 diabetes mellitus.

机构信息

Department of Nephrology, The Third Xiangya Hospital, Central South University, Changsha, P.R. China.

The Critical Kidney Disease Research Center of Central South University, Changsha, P.R. China.

出版信息

Ren Fail. 2023 Dec;45(1):2215880. doi: 10.1080/0886022X.2023.2215880.

DOI:10.1080/0886022X.2023.2215880
PMID:37246753
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10228320/
Abstract

PURPOSE

The purpose of this study was to investigate the association between serum proprotein convertase subtilisin/kexin type 9 (PCSK9) levels and renal function impairment in type 2 diabetes mellitus (T2DM) patients.

METHODS

PCSK9 levels were measured in T2DM patients, streptozotocin plus high-fat diet (STZ + HFD) mice, human proximal tubular epithelial (HK-2) cells treated with high glucose plus palmitic acid (HGPA) and the corresponding control groups. The T2DM patients were further divided into three groups according to serum PCSK9 levels. An analysis of clinical data was conducted, and a binary logistic regression model was used to test the relationship between potential predictors and urine albumin/urine creatinine ratio (UACR) and estimated glomerular filtration rate (eGFR).

RESULTS

PCSK9 levels were higher in the DM group than in the control group in humans, mice and HK-2 cells. The systolic blood pressure (SBP), serum creatinine (Scr), blood urea nitrogen (BUN), triglyceride (TG), and urine α1-MG/urine creatinine ratio (UαCR) values in PCSK9 tertile 3 were significantly higher than those in PCSK9 tertile 1 ( < 0.05). The DBP and UACR values were significantly higher in PCSK9 tertile 3 than in PCSK9 tertile 1 and PCSK9 tertile 2 (both  < 0.05). In addition, URCR values were significantly higher in PCSK9 tertile 3 and PCSK9 tertile 2 than in PCSK9 tertile 1 (both  < 0.05). Serum PCSK9 levels were positively correlated with SBP, Scr, BUN, TG, URCR, UαCR and UACR but inversely correlated with eGFR. In STZ + HFD mice, serum PCSK9 levels were positively correlated with Scr, BUN and UACR, which was consistent with the findings in the patients. A logistic regression model revealed that serum PCSK9 is an independent risk factor for UACR ≥30 mg/g and eGFR <60 mL/min/1.73 m. The ROC curve showed that 170.53 ng/mL and 337.26 ng/mL PCSK9 were the best cutoff values for UACR ≥30 mg/g and eGFR <60 mL/min/1.73 m, respectively.

CONCLUSION

Serum PCSK9 levels are associated with renal function impairment in T2DM patients and in some patients lower PCSK9 may be helpful to decrease chronic kidney disease.

摘要

目的

本研究旨在探讨血清前蛋白转化酶枯草溶菌素 9(PCSK9)水平与 2 型糖尿病(T2DM)患者肾功能损害的关系。

方法

检测 T2DM 患者、链脲佐菌素加高脂饮食(STZ+HFD)小鼠、高糖加棕榈酸处理的人近端肾小管上皮(HK-2)细胞及相应对照组的 PCSK9 水平。根据血清 PCSK9 水平将 T2DM 患者进一步分为三组。进行临床数据分析,并使用二元逻辑回归模型检验潜在预测因子与尿白蛋白/尿肌酐比值(UACR)和估算肾小球滤过率(eGFR)之间的关系。

结果

与对照组相比,人、鼠和 HK-2 细胞中的 DM 组 PCSK9 水平更高。PCSK9 三分位 3 组的收缩压(SBP)、血清肌酐(Scr)、血尿素氮(BUN)、甘油三酯(TG)和尿α1-MG/尿肌酐比值(UαCR)明显高于 PCSK9 三分位 1 组(均<0.05)。PCSK9 三分位 3 组的舒张压(DBP)和 UACR 明显高于 PCSK9 三分位 1 组和 PCSK9 三分位 2 组(均<0.05)。此外,PCSK9 三分位 3 组和 PCSK9 三分位 2 组的 URCR 值明显高于 PCSK9 三分位 1 组(均<0.05)。血清 PCSK9 水平与 SBP、Scr、BUN、TG、URCR、UαCR 和 UACR 呈正相关,与 eGFR 呈负相关。在 STZ+HFD 小鼠中,血清 PCSK9 水平与 Scr、BUN 和 UACR 呈正相关,与患者的结果一致。逻辑回归模型显示,血清 PCSK9 是 UACR≥30mg/g 和 eGFR<60mL/min/1.73m 的独立危险因素。ROC 曲线显示,170.53ng/mL 和 337.26ng/mL PCSK9 是 UACR≥30mg/g 和 eGFR<60mL/min/1.73m 的最佳截断值。

结论

血清 PCSK9 水平与 T2DM 患者的肾功能损害有关,在某些患者中,较低的 PCSK9 可能有助于降低慢性肾脏病的发生。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/852c/10228320/7b0a33964da6/IRNF_A_2215880_F0004_B.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/852c/10228320/839024042822/IRNF_A_2215880_F0001_B.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/852c/10228320/3364eeeb0025/IRNF_A_2215880_F0002_C.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/852c/10228320/ec19de7df8f8/IRNF_A_2215880_F0003_C.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/852c/10228320/7b0a33964da6/IRNF_A_2215880_F0004_B.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/852c/10228320/839024042822/IRNF_A_2215880_F0001_B.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/852c/10228320/3364eeeb0025/IRNF_A_2215880_F0002_C.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/852c/10228320/ec19de7df8f8/IRNF_A_2215880_F0003_C.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/852c/10228320/7b0a33964da6/IRNF_A_2215880_F0004_B.jpg

相似文献

1
Increased serum PCSK9 levels are associated with renal function impairment in patients with type 2 diabetes mellitus.血清 PCSK9 水平升高与 2 型糖尿病患者的肾功能损害有关。
Ren Fail. 2023 Dec;45(1):2215880. doi: 10.1080/0886022X.2023.2215880.
2
Decreased Serum Adipose Triglyceride Lipase Level Is Associated With Renal Function Impairment in Patients With Type 2 Diabetes.血清脂肪甘油三酯脂肪酶水平降低与2型糖尿病患者肾功能损害相关。
J Diabetes Res. 2025 Jul 24;2025:9987648. doi: 10.1155/jdr/9987648. eCollection 2025.
3
Clinical value of free ubiquitin in the identification of diabetic nephropathy in patients with type 2 diabetes mellitus and preliminary exploration of its protective effect.游离泛素在2型糖尿病患者糖尿病肾病识别中的临床价值及其保护作用的初步探索
BMC Nephrol. 2025 Jul 17;26(1):395. doi: 10.1186/s12882-025-04219-8.
4
Plasma proprotein convertase subtilisin/kexin type 9 (PCSK9) and the risk of chronic kidney disease progression in patients with type 2 diabetes.血浆前蛋白转化酶枯草溶菌素/克新9型(PCSK9)与2型糖尿病患者慢性肾病进展风险
Diabetes Obes Metab. 2025 Aug;27(8):4446-4453. doi: 10.1111/dom.16486. Epub 2025 May 29.
5
Disease Awareness in Patients With Type 2 Diabetes: Analysis of Baseline Data From the SMART-Finder Observational Study.2型糖尿病患者的疾病认知:来自SMART-Finder观察性研究的基线数据分析
JMIR Form Res. 2025 Feb 18;9:e60246. doi: 10.2196/60246.
6
Study on the modulation of kidney and liver function of rats with diabetic nephropathy by Huidouba through metabolomics.回豆巴通过代谢组学对糖尿病肾病大鼠肝肾功 能的调节作用研究
J Ethnopharmacol. 2025 Jun 11;351:120136. doi: 10.1016/j.jep.2025.120136.
7
The Impact of Primary Renal Diagnosis on Prognosis and the Varying Predictive Power of Albuminuria in the NURTuRE-CKD Study.NURTuRE-CKD研究中,原发性肾脏诊断对预后的影响及蛋白尿的不同预测能力。
Am J Nephrol. 2025;56(1):1-12. doi: 10.1159/000541770. Epub 2024 Oct 4.
8
Altered dietary salt intake for preventing diabetic kidney disease and its progression.改变膳食盐摄入量以预防糖尿病肾病及其进展。
Cochrane Database Syst Rev. 2023 Jan 16;1(1):CD006763. doi: 10.1002/14651858.CD006763.pub3.
9
Systematic review on urine albumin testing for early detection of diabetic complications.关于尿白蛋白检测用于早期发现糖尿病并发症的系统评价。
Health Technol Assess. 2005 Aug;9(30):iii-vi, xiii-163. doi: 10.3310/hta9300.
10
Association between serum tumor markers and diabetic nephropathy in type 2 diabetes patients: a cross-sectional survey in Western China.2型糖尿病患者血清肿瘤标志物与糖尿病肾病的关联:中国西部的一项横断面调查
BMC Endocr Disord. 2025 Jul 1;25(1):150. doi: 10.1186/s12902-025-01932-1.

引用本文的文献

1
Intersecting Pathways of Inflammation, Oxidative Stress, and Atherogenesis in the Evaluation of CKD: Emerging Biomarkers PCSK9, EPHX2, AOPPs, and TBARSs.慢性肾脏病评估中炎症、氧化应激与动脉粥样硬化发生的交叉途径:新兴生物标志物前蛋白转化酶枯草溶菌素9、环氧化物水解酶2、晚期氧化蛋白产物及硫代巴比妥酸反应物
Life (Basel). 2025 Aug 13;15(8):1287. doi: 10.3390/life15081287.
2
PCSK9 Inhibitors: A Potential Priority Choice for Lipid Management in Patients with Diabetic Kidney Disease.前蛋白转化酶枯草溶菌素9(PCSK9)抑制剂:糖尿病肾病患者脂质管理的潜在优先选择
Drugs. 2025 Aug 14. doi: 10.1007/s40265-025-02221-w.
3
Lipid abnormality in diabetic kidney disease and potential treatment advancements.

本文引用的文献

1
A novel mouse model of diabetes, atherosclerosis and fatty liver disease using an AAV8-PCSK9-D377Y injection and dietary manipulation in db/db mice.一种新型糖尿病、动脉粥样硬化和脂肪肝疾病的小鼠模型,通过 AAV8-PCSK9-D377Y 注射和 db/db 小鼠的饮食干预来建立。
Biochem Biophys Res Commun. 2022 Sep 24;622:163-169. doi: 10.1016/j.bbrc.2022.07.031. Epub 2022 Jul 15.
2
Proprotein convertase subtilisin/kexin type 9 (PCSK9) levels in primary antiphospholipid syndrome. The multicenter ATHERO-APS study.原发性抗磷脂综合征中前蛋白转化酶枯草溶菌素/kexin 9型(PCSK9)水平。多中心动脉粥样硬化抗磷脂综合征(ATHERO-APS)研究。
J Autoimmun. 2022 May;129:102832. doi: 10.1016/j.jaut.2022.102832. Epub 2022 May 2.
3
糖尿病肾病中的脂质异常及潜在治疗进展
Front Endocrinol (Lausanne). 2025 Mar 18;16:1503711. doi: 10.3389/fendo.2025.1503711. eCollection 2025.
4
PCSK9 inhibitor effectively alleviated cognitive dysfunction in a type 2 diabetes mellitus rat model.PCSK9 抑制剂有效缓解 2 型糖尿病大鼠模型的认知功能障碍。
PeerJ. 2024 Aug 14;12:e17676. doi: 10.7717/peerj.17676. eCollection 2024.
5
Lipid Toxicity in the Cardiovascular-Kidney-Metabolic Syndrome (CKMS).心血管-肾脏-代谢综合征(CKMS)中的脂质毒性
Biomedicines. 2024 Apr 29;12(5):978. doi: 10.3390/biomedicines12050978.
Pathophysiologic Mechanisms and Potential Biomarkers in Diabetic Kidney Disease.
糖尿病肾病的病理生理机制及潜在生物标志物。
Diabetes Metab J. 2022 Mar;46(2):181-197. doi: 10.4093/dmj.2021.0329. Epub 2022 Mar 24.
4
Metabolomics as a tool for the early diagnosis and prognosis of diabetic kidney disease.代谢组学作为糖尿病肾病早期诊断和预后评估的工具。
Med Res Rev. 2022 Jul;42(4):1518-1544. doi: 10.1002/med.21883. Epub 2022 Mar 10.
5
IDF Diabetes Atlas: Global, regional and country-level diabetes prevalence estimates for 2021 and projections for 2045.国际糖尿病联盟(IDF)糖尿病地图集:2021 年全球、区域和国家糖尿病患病率估算值以及 2045 年预测值。
Diabetes Res Clin Pract. 2022 Jan;183:109119. doi: 10.1016/j.diabres.2021.109119. Epub 2021 Dec 6.
6
Impact of PCSK9 Immunization on Glycemic Indices in Diabetic Rats.PCSK9 免疫接种对糖尿病大鼠血糖指标的影响。
J Diabetes Res. 2021 Aug 30;2021:4757170. doi: 10.1155/2021/4757170. eCollection 2021.
7
Cardiovascular Events with Finerenone in Kidney Disease and Type 2 Diabetes.在肾脏病和 2 型糖尿病患者中用非奈利酮发生的心血管事件。
N Engl J Med. 2021 Dec 9;385(24):2252-2263. doi: 10.1056/NEJMoa2110956. Epub 2021 Aug 28.
8
Vitamin D-VDR (vitamin D receptor) regulates defective autophagy in renal tubular epithelial cell in streptozotocin-induced diabetic mice via the AMPK pathway.维生素 D-VDR(维生素 D 受体)通过 AMPK 通路调节链脲佐菌素诱导的糖尿病小鼠肾小管上皮细胞中的缺陷自噬。
Autophagy. 2022 Apr;18(4):877-890. doi: 10.1080/15548627.2021.1962681. Epub 2021 Aug 25.
9
New insights into renal lipid dysmetabolism in diabetic kidney disease.糖尿病肾病中肾脏脂质代谢异常的新见解。
World J Diabetes. 2021 May 15;12(5):524-540. doi: 10.4239/wjd.v12.i5.524.
10
The predictive utility of circulating PCSK9 levels on diabetes mellitus.循环 PCSK9 水平对糖尿病的预测作用。
Cardiovasc Diabetol. 2021 Feb 13;20(1):45. doi: 10.1186/s12933-021-01226-5.